HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery.

Abstract
Current drug-delivery systems are designed primarily for parenteral applications and are either lipid or polymer drug conjugates. In our quest to inhibit herpes simplex virus infection via the compounds found in commonly used cosmetic products, we found that activated carbon particles inhibit infection and, in addition, substantially improve topical delivery and, hence, the efficacy of a common antiviral drug, acyclovir (ACV). Our in vitro studies demonstrate that highly porous carbon structures trapped virions, blocked infection and substantially improved efficacy when ACV was loaded onto them. Also, using murine models of corneal and genital herpes infections, we show that the topical use of drug-encapsulated carbon (DECON) reduced dosing frequency, shortened treatment duration, and exhibited higher therapeutic efficacy than currently approved topical or systemic antivirals alone. DECON is a nontoxic, cost-effective and nonimmunogenic alternative to current topical drug-delivery systems that is uniquely triggered for drug release by virus trapping.
AuthorsTejabhiram Yadavalli, Joshua Ames, Alex Agelidis, Rahul Suryawanshi, Dinesh Jaishankar, James Hopkins, Neel Thakkar, Lulia Koujah, Deepak Shukla
JournalScience advances (Sci Adv) Vol. 5 Issue 8 Pg. eaax0780 (08 2019) ISSN: 2375-2548 [Electronic] United States
PMID31453334 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antiviral Agents
  • Drug Carriers
  • Charcoal
  • Carbon
  • Acyclovir
Topics
  • Acyclovir (administration & dosage, therapeutic use)
  • Animals
  • Antiviral Agents (administration & dosage, therapeutic use)
  • CHO Cells
  • Carbon (chemistry)
  • Cell Line, Tumor
  • Charcoal (chemistry)
  • Chlorocebus aethiops
  • Corneal Diseases (drug therapy, virology)
  • Cricetulus
  • Disease Models, Animal
  • Drug Carriers (therapeutic use)
  • Female
  • HeLa Cells
  • Herpes Genitalis (drug therapy, virology)
  • Herpesvirus 1, Human (drug effects)
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: